The mechanism that gene MN1 uses to cause an aggressive AML subtype is better understood thanks to new research. Drugs targeting weak link in the chain of causation are in clinical trials for other subtypes.
The mechanism that gene MN1 uses to cause an aggressive AML subtype is better understood thanks to new research. Drugs targeting weak link in the chain of causation are in clinical trials for other subtypes.